BREAKING - Peer-Reviewed Study Links COVID-19 mRNA 'Vaccination' to Fatal Pulmonary Hemorrhage 555 Days Post-Injection Our autopsy case report is the first published instance of a fatal adverse event occurring more than one year post-mRNA injection, highlighting the potential for serious long-term adverse effects. A batch analysis revealed the BNT162b2 'vaccine' batch this patient received is among the top 2.8% for number of reported deaths out of all Pfizer COVID-19 'vaccine' batches and is associated with fatal cardiovascular adverse events including cardiac arrest. The biological plausibility of delayed pulmonary hemorrhage following COVID-19 mRNA vaccination is supported by documented short-term cases occurring soon after injection, regulatory concerns over prolonged genetic product effects, the persistence and pathogenicity of Spike protein, and emerging evidence of potential plasmid DNA genome integration contributing to sustained Spike protein expression. In conclusion, this man died of a cardiopulmonary arrest most likely as a result of acute pulmonary hemorrhage. The coronary artery disease was coincident but was not the primary cause of the cardiac arrest. Because the autopsy ruled out other possible causes of death and the received BNT162b2 'vaccine' batch is associated with fatal hematological, respiratory, and cardiovascular syndromes including cardiac arrest, prior COVID-19 vaccination is potentially either the direct cause or contributed to the causal pathway leading to death. Healthcare providers are encouraged to be aware of and monitor for any long-term cardiopulmonary complications that may arise after COVID-19 vaccination. @P_McCulloughMD @McCulloughFund